Korean J Pathol.
2000 Nov;34(11):934-940.
Expression Patterns of S100A6 Gene in Human Thyroid Diseases
- Affiliations
-
- 1Department of Pathology, Eulji University School of Medicine.
- 2Korea Research Institute of Bioscience and Biotechnology, Daejeon 301-070, Korea.
Abstract
-
S100A6 (calcyclin) is a member of the S100 family and has been originally
isolated from the cDNA library of Syrian baby hamster kidney cells. The S100A6 gene
expression is reported to remain high throughout the cell cycle following induction by
serum or growth factors, suggesting that the gene may be required for cell cycle
progression. Nevertheless, the role that S100A6 may play in tumor progression remains
unknown. In this study, we have explored the expression patterns of S100A6 gene in
human thyroid tissues by northern blot analysis. Using the S100A6 monoclonal antibody,
we carried out the immunohistochemical staining to determine the distribution/localization
of S100A6 protein within tumor or non-tumorous cells of the thyroid. To modulate the
regulation of endogenously expressed S100A6 protein in the intracellular level,
overexpressed or anti-sense treated transfectant was constructed by using the
eukaryotic expression vector. As a result, immunohistochemistry for S100A6 showed a
strong positivity in the malignant tumors of thyroid and a high expression level of
S100A6 protein affected cell proliferation in the overexpressed transfectant. These
findings suggest that S100A6 may be involved in the tumor pathogenesis and provides
another parameter for the differentiation of malignant and benign lesions. A well defined
monoclonal antibody against S100A6 protein is now available for the
immunohistochemical studies of the various thyroid tissues.